相关实验视频
Updated: Jun 6, 2025

05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
1.6K
通过激活DDIT4/AKT/mTOR信号通路,YTHDF2促进了厌塑性甲状腺癌的进展
Bao Dai1, Lei Xu1,2, Shikuo Rong3
1Department of Thyroid and Hernia Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, Guangdong, 510080, China.
Biology direct
|November 27, 2024
概括
增加YTHDF2的表达通过降解DDIT4mRNA,激活AKT/mTOR信号,并诱导EMT,促进甲状腺瘤 (ATC) 的进展. 这种表观遗传调节器可能是未来的ATC治疗点.
科学领域:
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子瘤学分子瘤学
- 在RNA生物学,RNA生物学.
背景情况:
- RNA甲基化是真核生物中关键的表观遗传修饰.
- 在形甲状腺癌 (ATC) 中,m6A阅读器YTH域家族2 (YTHDF2) 的作用及其机制仍然未被阐明.
研究的目的:
- 研究YTHDF2在甲状腺瘤 (ATC) 中的作用和机制.
主要方法:
- 使用生物信息学,组织样本,m6A点点,MeRIP-seq,RIP测试,RNA-seq,RNA稳定性和光酶测试.
- 进行了体外和体内实验,以评估YTHDF2对ATC发展的贡献.
主要成果:
- 在ATC中,YTHDF2的表达显著增加.
- YTHDF2的淘汰抑制了ATC的扩散,入侵,迁移,并促进了亡.
- YTHDF2通过m6A加速DDIT4mRNA降解,激活AKT/mTOR并促进EMT和瘤进展.
结论:
- 升高的YTHDF2抑制DDIT4,激活AKT/mTOR,并促进ATC的进展.
- YTHDF2在ATC进展中至关重要,并且代表了一个潜在的治疗点.
相关概念视频
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Synthesis and Regulation of Thyroid Hormones
4.2K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
4.2K
Receptor Tyrosine Kinases
12.3K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
12.3K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K

